TCG Crossover Management »

Mirum Pharmaceuticals shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.9M 62k 78.99

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cogent Biosciences Comm (COGT)
Cg Oncology Comm (CGON)
Tango Therapeutics Comm (TNGX)
Centessa Pharmaceuticals Adrs (CNTA)
Dyne Therapeutics Comm (DYN)
Rapt Therapeutics Comm (RAPT)
Tyra Biosciences Comm (TYRA)
Amylyx Pharmaceuticals Comm (AMLX)
Savara Comm (SVRA)
Monte Rosa Therapeutics Comm (GLUE)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Eyepoint Pharmaceuticals Comm (EYPT)
Structure Therapeutics Adrs (GPCR)

View all positions for TCG Crossover Management

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
Henderson Group
BlackRock
Vanguard Group
State Street Corporation
Eventide Asset Management
BVF
Novo A/S
Tang Capital Management
Citadel Advisors
Geode Capital Management
D. E. Shaw & Co
ClearBridge Advisors
Polar Capital Holdings
Wellington Management Company

View all funds holding Mirum Pharmaceuticals